Skip to main content
PHG
NYSE Life Sciences

Philips Posts Strong Q1 with 6% Order Growth, Margin Expansion; Reaffirms 2026 Outlook

feedReported by Dow Jones Newswires
Sentiment info
Positive
Importance info
8
Price
$26.69
Mkt Cap
$25.027B
52W Low
$21.95
52W High
$33.435
Market data snapshot near publication time

summarizeSummary

Koninklijke Philips NV reported a strong start to 2026, with Q1 comparable order intake growing 6% and comparable sales increasing 4%. The company also achieved margin expansion, with the adjusted EBITA margin rising 40 basis points to 9.0% and income from operations reaching EUR 241 million. These results demonstrate solid operational execution and growth across segments, particularly in North America and Europe. The reiteration of the full-year 2026 outlook signals management's confidence in maintaining this positive trajectory despite an uncertain macro-environment. Traders will view these results as a positive indicator of the company's ability to deliver on its strategic plan.

At the time of this announcement, PHG was trading at $26.69 on NYSE in the Life Sciences sector, with a market capitalization of approximately $25B. The 52-week trading range was $21.95 to $33.44. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


show_chartPrice Chart

Share this article

Copied!

feed PHG - Latest Insights

PHG
May 18, 2026, 4:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
PHG
May 06, 2026, 9:01 AM EDT
Filing Type: 6-K
Importance Score:
8
PHG
May 06, 2026, 1:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
PHG
Feb 19, 2026, 6:40 AM EST
Filing Type: 20-F
Importance Score:
9
PHG
Feb 19, 2026, 6:37 AM EST
Filing Type: 6-K
Importance Score:
8
PHG
Feb 10, 2026, 7:58 AM EST
Filing Type: 6-K
Importance Score:
8
PHG
Feb 10, 2026, 7:34 AM EST
Filing Type: 6-K
Importance Score:
9